Kiniksa Pharmaceuticals (NASDAQ:KNSA) Receives “Outperform” Rating from Wedbush
Kiniksa Pharmaceuticals (NASDAQ:KNSA – Get Free Report)‘s stock had its “outperform” rating reaffirmed by Wedbush in a research report issued on Monday,RTT News reports. They presently have a $34.00 price objective on the stock. Wedbush’s price target would suggest a potential upside of 85.39% from the stock’s current price. KNSA has been the subject of […]
More Stories
Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) To Go Ex-Dividend on January 14th
Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE:FOF – Get Free Report) announced a dividend on Monday, January 13th,investing.com reports....
InnSuites Hospitality Trust (IHT) To Go Ex-Dividend on January 24th
InnSuites Hospitality Trust (NYSE:IHT – Get Free Report) declared a semi-annual dividend on Monday, January 13th,Wall Street Journal reports. Investors...
Neuberger Berman Real Estate Securities Income Fund Inc. (NYSEAMERICAN:NRO) Announces $0.03 Monthly Dividend
Neuberger Berman Real Estate Securities Income Fund Inc. (NYSEAMERICAN:NRO – Get Free Report) announced a monthly dividend on Monday, January...
Aberdeen Total Dynamic Dividend Fund (AOD) To Go Ex-Dividend on January 24th
Aberdeen Total Dynamic Dividend Fund (NYSE:AOD – Get Free Report) declared a monthly dividend on Monday, January 13th,Wall Street Journal...
Option Care Health (NASDAQ:OPCH) Issues FY25 Earnings Guidance
Option Care Health (NASDAQ:OPCH – Get Free Report) updated its FY25 earnings guidance on Monday morning. The company provided earnings...
Flowers Foods (NYSE:FLO) Sets New 52-Week Low – Here’s Why
Flowers Foods, Inc. (NYSE:FLO – Get Free Report)’s stock price reached a new 52-week low during trading on Monday ....